CVR: 39189135
DKK 4,626,954
Gross profit
Net result: DKK -338,581
PROSAL ApS, ASTIM Holding ApS
1 more
CVR · view ownership and management
Director registered: Søren Buus
CVR · 21/06/2018
View the full event history
immunAware ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye. The company is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS. In 2025, the company reported a gross profit of DKK 4,626,954 and a net result of DKK -338,581 compared with DKK -757,428 the year before. Equity in the 2025 report amounted to DKK 4,913,587.
Source: annual report 2025, Danish Business Authority
The financial health of immunAware ApS appears to be improving, with a notable increase in gross profit from 3,427,889 DKK in 2021 to 5,438,301 DKK in 2023. However, the company reported a loss of 338,581 DKK in 2025, indicating challenges in achieving profitability despite strong gross profit margins. Equity has decreased from 6,169,596 DKK in 2023 to 4,913,587 DKK in 2025, raising concerns about financial stability. Overall, while the company shows potential in gross profit growth, its profitability and equity trends suggest a need for strategic adjustments to enhance its position within the research and experimental development sector.
AI-generated summary · Generated 16/08/2026
Selskabet har til formål at udføre forsknings- og udviklingsaktiviteter med henblik på at tilbyde forskere i hele verden reagenser og service relateret til histocompatibilitets kompleks (MHC) klasse I og II molekyler, og at udføre sådanne aktiviteter, som direktionen skønsmæssigt måtte finde relaterende hertil.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 4.6 mio. | -339 t. | 5.2 mio. | 4.9 mio. | 9 | |
| 202401/01/2024 – 31/12/2024 | 4.1 mio. | -757 t. | 5.8 mio. | 5.3 mio. | 8 | |
| 202301/01/2023 – 31/12/2023 | 5.4 mio. | 1.3 mio. | 7.1 mio. | 6.2 mio. | 6 | |
| 202201/01/2022 – 31/12/2022 | 5.1 mio. | 1.6 mio. | 5.5 mio. | 5 mio. | 5 | |
| 202101/01/2021 – 31/12/2021 | 3.4 mio. | 1.2 mio. | 4.2 mio. | 3.6 mio. | 3 | |
| 202001/01/2020 – 31/12/2020 | 2.4 mio. | 1.2 mio. | 3.2 mio. | 2.6 mio. | 1 | |
| 201901/01/2019 – 31/12/2019 | 2.3 mio. | 1.4 mio. | 2 mio. | 1.5 mio. | 1 | |
| 201819/12/2017 – 31/12/2018 | 25 t. | 19 t. | 167 t. | 151 t. | 0 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorimmunAware ApS was founded on 19 December 2017.
immunAware ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
immunAware ApS is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS.
immunaware.com belongs to immunAware ApS, CVR number 39189135.
In 2025, immunAware ApS reported a gross profit of DKK 4,626,954.
The management of immunAware ApS consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye.
Claim this page to add your logo and social links. Free to get started.
ImmunAware ApS has published its annual report for 2025. Gross profit came to DKK 4,626,954, and the net result was DKK -338,581.
ImmunAware ApS has published its annual report for 2024. Gross profit came to DKK 4,057,989, and the net result was DKK -757,428.
ImmunAware ApS has published its annual report for 2023. Gross profit came to DKK 5,438,301, and the net result was DKK 1,308,604.
ImmunAware ApS has published its annual report for 2022. Gross profit came to DKK 5,094,846, and the net result was DKK 1,567,432.
As of June 9, 2023, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of immunAware ApS.
ImmunAware ApS has published its annual report for 2021. Gross profit came to DKK 3,427,889, and the net result was DKK 1,182,833.
ImmunAware ApS has published its annual report for 2020. Gross profit came to DKK 2,395,210, and the net result was DKK 1,211,357.
ImmunAware ApS has published its annual report for 2019. Gross profit came to DKK 2,283,575, and the net result was DKK 1,388,135.
ImmunAware ApS has published its annual report for 2018. Gross profit came to DKK 24,983, and the net result was DKK 18,735.
As of June 21, 2018, Søren Buus is registered as director of immunAware ApS.
As of June 21, 2018, Anette Stryhn Buus is registered as adm. dir. of immunAware ApS.
As of June 20, 2018, Søren Buus has stepped down as adm. dir. of immunAware ApS.
As of June 20, 2018, Anette Stryhn Buus has stepped down as director of immunAware ApS.
As of December 19, 2017, Søren Buus is registered as adm. dir. of immunAware ApS.
As of December 19, 2017, Anette Stryhn Buus is registered as director of immunAware ApS.
As of December 19, 2017, Thomas Østerbye is registered as director of immunAware ApS.
As of December 19, 2017, PROSAL ApS is registered as an owner of immunAware ApS with an ownership share of 33%.
As of December 19, 2017, ASTIM Holding ApS is registered as an owner of immunAware ApS with an ownership share of 25%.
As of December 19, 2017, T.Ø. Holding ApS is registered as an owner of immunAware ApS with an ownership share of 25%.
ImmunAware ApS was founded on December 19, 2017.
Companies in the same industry and area
CVR 29312206
CVR 37053678
CVR 37726028
CVR 29217939
CVR 31762863
